Related Experiment Video

Updated: May 15, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

The incidence and clinical relevance of drug interactions in pediatrics

Hasime Qorraj-Bytyqi1, Rexhep Hoxha, Shaip Krasniqi

  • 1Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo, Yugoslavia.

Journal of Pharmacology & Pharmacotherapeutics
|January 18, 2013
PubMed

Insights

Drug interactions are a significant risk in hospitalized children, with pharmacokinetic interactions being common. Implementing improved prescription systems and pharmacist involvement can enhance patient safety.

Area of Science:

  • Pediatric Pharmacology
  • Clinical Pharmacy
  • Drug Safety

Background:

  • Drug interactions pose a continuous risk in pediatric healthcare settings.
  • Understanding the prevalence and profile of these interactions is crucial for patient safety.

Purpose of the Study:

  • To determine the frequency and characteristics of major drug interactions in hospitalized children.
  • To analyze the rate and profile of drug interactions within a pediatric clinic.

Main Methods:

  • A retrospective study design was employed.
  • Data were collected from medical records of children hospitalized in Pulmonology, Nephrology, and Gastroenterology wards between July 1999 and 2004.

Main Results:

  • 34 drug interactions were identified: 1 pharmacodynamic, 13 pharmacokinetic, and 20 with unknown mechanisms.
  • Interactions varied in significance, severity (7 major, 19 moderate, 8 minor), and onset (33 delayed).

Conclusions:

  • Drug interactions represent an ongoing concern in pediatric clinical practice.
  • Strategies to mitigate risks include continuous education, computerized prescription systems, pharmacotherapy monitoring, and multidisciplinary team collaboration involving pharmacists.
Abstract

Keywords:
Childrendrug interactionstherapy

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...